1,886
Participants
Start Date
August 18, 2014
Primary Completion Date
April 18, 2015
Study Completion Date
April 18, 2015
Influsplit Tetra™ vaccine produced by investigational process (IP)
Influsplit Tetra™ vaccine using a new manufacturing process administered intramuscularly (IM) in the deltoid region of non-dominant arm (Dose 1) in Adults Group and in non-dominant deltoid or left anterolateral thigh (Dose 1) and dominant deltoid or right anterolateral (Dose 2 - unprimed subjects) in 6-35m and 3-17y Groups.
Influsplit Tetra™ vaccine produced by licensed process (LP)
Influsplit Tetra™ vaccine using a licensed manufacturing process administered IM in the deltoid region of non-dominant arm (Dose 1) in Adults Group and in non-dominant deltoid or left anterolateral thigh (Dose 1) and dominant deltoid or right anterolateral (Dose 2 - unprimed subjects) in 6-35m and 3-17y Groups.
GSK Investigational Site, Dhaka
GSK Investigational Site, Prague
GSK Investigational Site, Berlin
GSK Investigational Site, Aix-en-Provence
GSK Investigational Site, Rochester
GSK Investigational Site, Santiago de Compostela
GSK Investigational Site, Neumünster
GSK Investigational Site, Flensburg
GSK Investigational Site, Odolena Voda
GSK Investigational Site, Madrid
GSK Investigational Site, Antequera/Málaga
GSK Investigational Site, Löhne
GSK Investigational Site, Detmold
GSK Investigational Site, Nashville
GSK Investigational Site, Jindřichův Hradec
GSK Investigational Site, Dax
GSK Investigational Site, Seville
GSK Investigational Site, Nantes
GSK Investigational Site, Essen
GSK Investigational Site, Essen
GSK Investigational Site, Kleve-Materborn
GSK Investigational Site, Goch
GSK Investigational Site, Chlumec nad Cidlinou
GSK Investigational Site, Essey-lès-Nancy
GSK Investigational Site, Trier
GSK Investigational Site, Wichita
GSK Investigational Site, Stuttgart
GSK Investigational Site, Ostrava - Poruba
GSK Investigational Site, Lipník nad Bečvou
GSK Investigational Site, Le Havre
GSK Investigational Site, Kehl
GSK Investigational Site, Draguignan
GSK Investigational Site, Schönau am Königssee
GSK Investigational Site, Kirchheim
GSK Investigational Site, Würzburg
GSK Investigational Site, Warwick
GSK Investigational Site, Brno
GSK Investigational Site, Děčín
GSK Investigational Site, Liberec
GSK Investigational Site, Náchod
GSK Investigational Site, Pardubice
GSK Investigational Site, Nice
GSK Investigational Site, Leipzig
GSK Investigational Site, Radebeul
GSK Investigational Site, Wurzen
GSK Investigational Site, Bydgoszcz
GSK Investigational Site, Dębica
GSK Investigational Site, Katowice
GSK Investigational Site, Poznan
GSK Investigational Site, Siemianowice Śląskie
GSK Investigational Site, Wroclaw
GSK Investigational Site, Badalona
GSK Investigational Site, Burgos
Lead Sponsor
GlaxoSmithKline
INDUSTRY